🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andreas du Bois

Kliniken Essen-Mitte

ORCID: 0000-0002-8477-506X
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.350Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.16.146803
Top 50%
0.350DataRank
Top 50%8 citations

Sara Lindström, Rayjean J. Hung, Kate Lawrenson, Marjanka K. Schmidt, Tracy A. O’Mara +95 more

Papers

Driven by 10 papers — median percentile 50. Top paper: “Polygenic risk modeling for prediction of epithelial ovarian cancer risk”.

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

European Journal of Human Genetics(2022)10.1038/s41431-021-00987-7
N/A
0.646DataRank · unranked
73 citations

Jonathan P. Tyrer, Daniel R. Barnes, Michelle R. Jones, Xin Yang, Katja K. H. Aben +90 more

Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial

JCO Precision Oncology(2023)10.1200/po.22.00258
N/A
0.612DataRank · unranked
58 citations

Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W. Criscione +16 more

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.04.011
N/A
0.489DataRank · unranked
25 citations

Simon G. Coetzee, Jonathan P. Tyrer, Pei-Chen Peng, Will Rosenow, Stephanie Chen +95 more

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1817
N/A
0.396DataRank · unranked
13 citations

Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese +62 more

Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.16.146803
Top 50%
0.350DataRank
Top 50%8 citations

Sara Lindström, Rayjean J. Hung, Kate Lawrenson, Marjanka K. Schmidt, Tracy A. O’Mara +95 more

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

The Lancet Oncology(2022)10.1016/s1470-2045(22)00139-5
N/A
0DataRank · unranked
142 citations

Antonio González-Martı́n, Domenica Lorusso, Charlie Gourley, Mansoor Raza Mirza, Jean‐Emmanuel Kurtz +73 more

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.

Apollo (University of Cambridge)(2021)10.17863/cam.126709
N/A
0DataRank · unranked
0 citations

Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese +65 more

Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma

medRxiv(2021)10.1101/2021.09.16.21262993
N/A
0DataRank · unranked
4 citations

Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu +77 more

Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.08.019
N/A
0DataRank · unranked
5 citations

Silvana Pedra Nobre, Dib Sassine, Gretchen Glaser, Ane Gerda Zahl Eriksson, Beyhan Ataseven +7 more

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin(2021)10.1007/s00428-021-03232-0
N/A
0DataRank · unranked
23 citations

Joshua Millstein, Gordana Popović, Nicola S. Meagher, Adelyn Bolithon, Aline Talhouk +95 more